Source disclosure: February 09, 2026
Kringle Pharma,Inc. [4884.T]
TOKYO, Feb 18 (Pulse News Wire) – Kringle Pharma,Inc. (4884.T) reported consolidated results for Q1 FY2026 (ending September 2026).
2% YoY).
99 billion with an equity ratio of 59.7%.
For the next fiscal year, the company forecasts 3%).
Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.
AI-translated content. 🟢 Confidence: High See terms • Original filing💬 Help us improve translation quality
Notice any errors in this article? Let us know with one click.